Web Results

en.wikipedia.org/wiki/David_Farragut

David Glasgow Farragut /ˈfærəɡət was a flag officer of the United States Navy during the American Civil War. He was the first rear admiral, vice admiral, and admiral in the United States Navy. He is remembered for his order at the Battle of Mobile Bay usually paraphrased as "Damn the torpedoes, full speed ahead" in U.S. ...

www.ncbi.nlm.nih.gov/pubmed/21670448

J Clin Oncol. 2011 Jul 20;29(21):2889-96. doi: 10.1200/JCO.2011.35.4894. Epub 2011 Jun 13. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. Thol F(1), Damm F, Lüdeking A, Winschel C, Wagner K, Morgan M, Yun H, Göhring G, Schlegelberger B, Hoelzer D, Lübbert M, Kanz L, ...

www.ncbi.nlm.nih.gov/pubmed/22343920

Feb 17, 2012 ... Damm F(1), Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo- Curtis C, Della Valle V, Couronné L, Scourzic L, Chesnais V, Guerci-Bresler A, Slama B, Beyne-Rauzy O, Schmidt-Tanguy A, Stamatoullas-Bastard A, Dreyfus F, Prébet T, de Botton S, Vey N, Morgan MA, Cross NC, Preudhomme ...

onlinelibrary.wiley.com/doi/10.1111/bjh.12298/full

Mar 25, 2013 ... Previously, we found MT-ND4 variants in 6·4% of adult AML cases and somatic MT-ND4 variants were associated with improved survival (Damm et al, 2012). .... Mixed-lineage-leukaemia (MLL)-rearrangements were more common in MT-ND4 variant than in MT-ND4wildtype study patients (46% (6/13) vs.

ascopubs.org/doi/full/10.1200/jco.2010.31.1118

(C) Overall survival and (D) relapse-free survival of patients with core-binding factor acute myeloid leukemia according to high v low MLL5 expression levels ( log-rank test). ..... F Damm, M Heuser, M Morgan, etal: Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with ...

www.bloodjournal.org/content/bloodjournal/116/4/614.full.pdf

Jul 29, 2010 ... Felicitas Thol,1 Frederik Damm,1 Katharina Wagner,1 Gudrun Gö hring,2 Brigitte Schlegelberger,2 Dieter Hoelzer,3. Michael Lü bbert,4 Wolfgang .... clinical and hematologic characteristics of IDH2-mutated versus unmutated CN-AML patients, .... 27(18):3000-3006. 12. Damm F, Heuser M, Morgan M, et al.

ascopubs.org/doi/full/10.1200/jco.2011.35.4894

A total of 489 patients with AML were examined for mutations in DNMT3A by direct sequencing. The prognostic impact of DNMT3A mutations was evaluated in the context of other clinical prognostic markers and genetic risk factors ( cytogenetic risk group; mutations in NPM1, FLT3, CEBPA, IDH1, IDH2, MLL1, NRAS, WT1, ...

www.sciencedirect.com/science/article/pii/001429998490462X

Jan 27, 1984 ... References. Damm et al., 1979. H.W. Damm, W.E. Muller, U. WollertIs the benzodiazepine receptor purinergic? European J. Pharmacol., 55 (1979), p. 331 ... et al., 1983. P.F. Morgan, H.G.E. Lloyd, T.W. StoneBenzodiazepine inhibition of adenosine uptake is not prevented by benzodiazepine antagonists.

caselaw.findlaw.com/us-supreme-court/010818zor.html

Jan 8, 2018 ... V. WALL-STREET.COM, LLC, ET AL. The Solicitor General is invited to file briefs in these. cases expressing the views of the United States. 17-5256 DAKER, WASEEM V. TOOLE, ... 17-363 VELERON HOLDING, B.V. V. MORGAN STANLEY, ET AL. ..... 17-6747 DAMM, GREGORY P. V. UNITED STATES.